BAL101553

Known as: Microtubule-targeted Agent BAL101553 
An orally available, highly water-soluble lysine prodrug of the synthetic small molecule BAL27862 with potential antitumor activity. Upon… (More)
National Institutes of Health

Topic mentions per year

Topic mentions per year

2014-2018
0120142018

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
Human glioblastoma (GBM) is a highly aggressive, invasive and hypervascularised malignant brain cancer. Individual circulating… (More)
  • figure 1
Is this relevant?
2017
2017
BACKGROUND AND PURPOSE Resistance to microtubule targeting agents (MTA) represents a major drawback in successful cancer therapy… (More)
Is this relevant?
2016
2016
Glioblastoma patients have limited treatment options. Cancer stem-like cells (CSLC) contribute to glioblastoma invasiveness and… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
2015
2015
BAL101553 is a highly water soluble prodrug of BAL27862 that arrests tumor cell proliferation and induces cell death in cancer… (More)
Is this relevant?
2014
2014
Microtubule-targeting agents are widely used for the treatment of cancer and as tool compounds to study the microtubule… (More)
  • figure 1
  • figure 2
  • table 1
  • figure 3
  • figure 4
Is this relevant?